<DOC>
	<DOCNO>NCT01874535</DOCNO>
	<brief_summary>To investigate impact initial treatment duration ( 4-week versus 8-week ) Esomeprazole ( 40mg ) rate symptom relapse sustain heal esophagitis patient symptomatic erosive esophagitis</brief_summary>
	<brief_title>Rate Complete Symptom Relief , Prevention Symptom Relapse : Grades A B Esophagitis Esomeprazole Therapy</brief_title>
	<detailed_description>Patients : Patients age 15 80 year clinical symptom acid regurgitation , heart burn , feel acidity stomach , Los Angeles Grade A B erosive esophagitis proven endoscopy recruit . Criteria exclusion include ( 1 ) coexistence peptic ulcer gastrointestinal malignancy , ( 2 ) pregnancy , ( 3 ) coexistence serious concomitant illness ( example , decompensated liver cirrhosis uremia ) , ( 4 ) previous gastric surgery , ( 5 ) allergy esomeprazole , ( 6 ) symptom score validate questionnaire ( Chinese GERDQ ) less 12 , ( 7 ) equivocal endoscopic diagnosis Los Angeles Grade A B erosive esophagitis . Outcome parameter : The main outcome measure 1 . Rate complete symptom relief ( CSR ) end initial treatment phase 2. rate symptom relapse within 12 week stop initial therapy</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>patient age 15 80 year clinical symptom acid regurgitation , heart burn , feel acidity stomach , Los Angeles Grade A B erosive esophagitis proven endoscopy recruit . 1. coexistence peptic ulcer gastrointestinal malignancy , 2. pregnancy , 3. coexistence serious concomitant illness ( example , decompensated liver cirrhosis uremia ) , 4. previous gastric surgery , 5. allergy esomeprazole , 6. symptom score validate questionnaire ( Chinese GERDQ ) less 12 , 7. equivocal endoscopic diagnosis Los Angeles Grade A B erosive esophagitis .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>